Suzanne C. Cannegieter

Suzanne C. Cannegieter's AcademicInfluence.com Rankings

Physics

#6859

World Rank

#8849

Historical Rank

physics Degrees

Download Badge

Physics

Suzanne C. Cannegieter's Degrees

PhD Physics University of Amsterdam
Masters Physics University of Amsterdam
Bachelors Physics University of Amsterdam

Why Is Suzanne C. Cannegieter Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Suzanne C. Cannegieter's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy (1993) (1958)
Incidence and mortality of venous thrombosis: a population‐based study (2007) (1240)
Thromboembolic and Bleeding Complications in Patients With Mechanical Heart Valve Prostheses (1994) (1008)
Optimal oral anticoagulant therapy in patients with mechanical heart valves. (1995) (944)
Epidemiology of cancer-associated venous thrombosis. (2013) (816)
Thrombophilia, clinical factors, and recurrent venous thrombotic events. (2005) (574)
Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH (2016) (344)
Multisystem morbidity and mortality in Cushing's syndrome: a cohort study. (2013) (310)
Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature (2017) (295)
Use of Glucocorticoids and Risk of Venous Thromboembolism (2013) (283)
Travel-Related Venous Thrombosis: Results from a Large Population-Based Case Control Study (MEGA Study) (2006) (216)
Risk factors for venous thrombosis – current understanding from an epidemiological point of view (2010) (190)
Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence (2007) (162)
Incidence of venous thromboembolism in patients with Cushing's syndrome: a multicenter cohort study. (2011) (154)
The Absolute Risk of Venous Thrombosis after Air Travel: A Cohort Study of 8,755 Employees of International Organisations (2007) (144)
Clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism: A different phenotype of thrombotic disease? (2020) (141)
Pulmonary embolism (2018) (124)
Sex Difference in Risk of Second but Not of First Venous Thrombosis: Paradox Explained (2014) (113)
Arterial cardiovascular risk factors and venous thrombosis: results from a population-based, prospective study (the HUNT 2) (2010) (110)
Major Bleeding Rates in Atrial Fibrillation Patients on Single, Dual, or Triple Antithrombotic Therapy: Results From a Nationwide Danish Cohort Study (2019) (107)
Association of Mild to Moderate Chronic Kidney Disease With Venous Thromboembolism: Pooled Analysis of Five Prospective General Population Cohorts (2012) (105)
Bleeding in patients receiving vitamin K antagonists who would have been excluded from trials on which the indication for anticoagulation was based. (2008) (105)
Finding the origin of pulmonary emboli with a total-body magnetic resonance direct thrombus imaging technique (2013) (100)
Thromboprophylaxis after Knee Arthroscopy and Lower‐Leg Casting (2017) (100)
Long-Term Survival in a Large Cohort of Patients with Venous Thrombosis: Incidence and Predictors (2012) (99)
Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients. (2011) (98)
Broadening the factor V Leiden paradox: pulmonary embolism and deep-vein thrombosis as 2 sides of the spectrum. (2012) (97)
Differential risks in men and women for first and recurrent venous thrombosis: the role of genes and environment (2014) (97)
Relationship between venous and arterial thrombosis: a review of the literature from a causal perspective. (2011) (95)
Outcome after ST elevation myocardial infarction in patients with cancer treated with primary percutaneous coronary intervention. (2013) (89)
Association of Traditional Cardiovascular Risk Factors With Venous Thromboembolism: An Individual Participant Data Meta-Analysis of Prospective Studies. (2017) (87)
Hematologic variables and venous thrombosis: red cell distribution width and blood monocyte count are associated with an increased risk (2014) (86)
Intramyocardial Injection of Autologous Bone Marrow-Derived Ex Vivo Expanded Mesenchymal Stem Cells in Acute Myocardial Infarction Patients is Feasible and Safe up to 5 Years of Follow-up (2013) (85)
Recurrent Implantable Cardioverter‐Defibrillator Replacement Is Associated with an Increasing Risk of Pocket‐Related Complications (2010) (84)
Risk of venous thrombosis in patients with major illnesses: results from the MEGA study (2013) (84)
Optimal intensity of oral anticoagulant therapy after myocardial infarction. (1996) (83)
Statin use and venous thromboembolism recurrence: a combined nationwide cohort and nested case–control study (2014) (81)
Increasing levels of free thyroxine as a risk factor for a first venous thrombosis: a case-control study. (2010) (79)
Inflammatory Cytokines as Risk Factors for a First Venous Thrombosis: A Prospective Population-Based Study (2006) (74)
Cardiac device infections are associated with a significant mortality risk. (2012) (74)
Quantification of bias in direct effects estimates due to different types of measurement error in the mediator. (2012) (74)
The clinical course of patients with implantable cardioverter-defibrillators: Extended experience on clinical outcome, device replacements, and device-related complications. (2015) (73)
Primary postpartum haemorrhage in women with von Willebrand disease or carriership of haemophilia despite specialised care: a retrospective survey (2015) (72)
The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment (2015) (72)
Severe coagulation factor V deficiency caused by a 4 bp deletion in the factor V gene (1998) (70)
Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave (2020) (69)
A prospective study of anticardiolipin antibodies as a risk factor for venous thrombosis in a general population (the HUNT study) (2006) (69)
Towards a tailored diagnostic standard for future diagnostic studies in pulmonary embolism: communication from the SSC of the ISTH (2017) (69)
Type-specific risk factors and outcome in an outbreak with 2 different Clostridium difficile types simultaneously in 1 hospital. (2011) (66)
High levels of coagulation factors and venous thrombosis risk: strongest association for factor VIII and von Willebrand factor (2019) (62)
Healthcare and disease burden among refugees in long-stay refugee camps at Lesbos, Greece (2017) (61)
Risk of venous and arterial thrombotic events in patients diagnosed with superficial vein thrombosis: a nationwide cohort study. (2015) (61)
Predictive value of factor VIII levels for recurrent venous thrombosis: results from the MEGA follow‐up study (2015) (61)
Prospective study of homocysteine and MTHFR 677TT genotype and risk for venous thrombosis in a general population – results from the HUNT 2 study (2008) (60)
Risk of Cerebral Venous Thrombosis in Obese Women. (2016) (59)
Risk Factors for Cerebral Venous Thrombosis (2016) (58)
Contrast-induced acute kidney injury and clinical outcomes after intra-arterial and intravenous contrast administration: risk comparison adjusted for patient characteristics by design. (2013) (57)
Influence of gender on ischemic times and outcomes after ST-elevation myocardial infarction. (2013) (57)
Increased risk of venous thrombosis in persons with clinically diagnosed superficial vein thrombosis: results from the MEGA study. (2011) (55)
Below‐knee cast immobilization and the risk of venous thrombosis: results from a large population‐based case–control study (2014) (54)
Coagulation abnormalities in Legg-Calvé-Perthes disease. (2010) (54)
Association Between Anemia and Cerebral Venous Thrombosis: Case–Control Study (2015) (54)
Prehospital use in emergency patients of a laryngeal mask airway by ambulance paramedics is a safe and effective alternative for endotracheal intubation (2013) (51)
Genetic Variations Associated With Recurrent Venous Thrombosis (2014) (50)
The spatial QRS-T angle in the Frank vectorcardiogram: accuracy of estimates derived from the 12-lead electrocardiogram. (2010) (50)
Role of Obesity in the Etiology of Deep Vein Thrombosis and Pulmonary Embolism: Current Epidemiological Insights (2013) (50)
A randomized comparison of 1-h sodium bicarbonate hydration versus standard peri-procedural saline hydration in patients with chronic kidney disease undergoing intravenous contrast-enhanced computerized tomography. (2014) (49)
Acute cardiovascular events and all-cause mortality in patients with hyperthyroidism: a population-based cohort study. (2017) (49)
Alterations in coagulation and fibrinolysis after levothyroxine exposure in healthy volunteers: a controlled randomized crossover study (2011) (48)
The risk of venous thrombosis in individuals with a history of superficial vein thrombosis and acquired venous thrombotic risk factors. (2013) (48)
Understanding the Health of Scotland's Population in an International Context (2003) (47)
Pneumonia and risk of venous thrombosis: results from the MEGA study (2012) (46)
Risk of venous thrombosis after arthroscopy of the knee: results from a large population‐based case–control study (2015) (45)
The effect of flight‐related behaviour on the risk of venous thrombosis after air travel (2009) (45)
Current and future burden of venous thrombosis: Not simply predictable (2018) (44)
Randomised trial of no hydration vs. sodium bicarbonate hydration in patients with chronic kidney disease undergoing acute computed tomography–pulmonary angiography (2014) (44)
Role of Hemostatic Factors on the Risk of Venous Thrombosis in People With Impaired Kidney Function (2014) (44)
Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients. (2009) (44)
Impact of Incident Venous Thromboembolism on Risk of Arterial Thrombotic Diseases (2014) (44)
Rosuvastatin use improves measures of coagulation in patients with venous thrombosis (2018) (43)
Continuation of low‐molecular‐weight heparin treatment for cancer‐related venous thromboembolism: a prospective cohort study in daily clinical practice (2017) (43)
Risk of venous thrombosis in patients with chronic kidney disease: identification of high‐risk groups (2013) (43)
Effect of elevated levels of coagulation factors on the risk of venous thrombosis in long-distance travelers. (2009) (41)
Diversity and Clinical Impact of Acinetobacter baumannii Colonization and Infection at a Military Medical Center (2010) (40)
Early Reperfusion Therapy Affects Inducibility, Cycle Length, and Occurrence of Ventricular Tachycardia Late After Myocardial Infarction (2011) (40)
Driving restrictions after implantable cardioverter defibrillator implantation: an evidence-based approach (2011) (39)
The impact of initial cancer stage on the incidence of venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) Cohort (2017) (39)
Risk of a Recurrent Cardiovascular Event in Individuals With Type 2 Diabetes or Intermediate Hyperglycemia (2013) (38)
Efficacy and Safety of Vitamin K-Antagonists (VKA) for Atrial Fibrillation in Non-Dialysis Dependent Chronic Kidney Disease (2014) (37)
Venous thromboembolism and subsequent permanent work‐related disability (2016) (36)
Five-year clinical follow-up from the MISSION! Intervention Study: sirolimus-eluting stent versus bare metal stent implantation in patients with ST-segment elevation myocardial infarction, a randomised controlled trial. (2012) (36)
Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts (2016) (36)
Pulse wave velocity and flow in the carotid artery versus the aortic arch: Effects of aging (2014) (36)
Fluid loss does not explain coagulation activation during air travel (2008) (35)
Risk of thrombotic complications in influenza versus COVID‐19 hospitalized patients (2020) (35)
The relationship between body mass index, activated protein C resistance and risk of venous thrombosis (2012) (35)
Cancer and risk of cerebral venous thrombosis: a case–control study (2018) (34)
Venous Thrombosis Risk after Cast Immobilization of the Lower Extremity: Derivation and Validation of a Clinical Prediction Score, L-TRiP(cast), in Three Population-Based Case–Control Studies (2015) (34)
High levels of procoagulant factors mediate the association between free thyroxine and the risk of venous thrombosis: the MEGA study (2014) (33)
Prophylactic implantable cardioverter-defibrillator treatment in the elderly: therapy, adverse events, and survival gain. (2012) (33)
Hypofibrinolysis as a risk factor for recurrent venous thrombosis; results of the LETS follow‐up study (2010) (32)
Risk and Risk Factors Associated With Recurrent Venous Thromboembolism Following Surgery in Patients With History of Venous Thromboembolism (2019) (32)
The effect of changes in thyroxine and thyroid‐stimulating hormone levels on the coagulation system (2010) (32)
The incidence of venous thromboembolism in patients with overt hyperthyroidism (2012) (31)
Increased risk of CVD after VT is determined by common etiologic factors. (2013) (31)
Effect of No Prehydration vs Sodium Bicarbonate Prehydration Prior to Contrast-Enhanced Computed Tomography in the Prevention of Postcontrast Acute Kidney Injury in Adults With Chronic Kidney Disease: The Kompas Randomized Clinical Trial. (2020) (30)
Lipid levels and risk of venous thrombosis: results from the MEGA-study (2017) (30)
COVID‐19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance (2020) (29)
Postpartum Period Is a Risk Factor for Cerebral Venous Thrombosis: A Case-Control Study (2019) (29)
Venous thrombosis: understanding the paradoxes of recurrence (2013) (28)
Sex difference in the risk of recurrent venous thrombosis: a detailed analysis in four European cohorts (2015) (28)
Influence of the vectorcardiogram synthesis matrix on the power of the electrocardiogram-derived spatial QRS-T angle to predict arrhythmias in patients with ischemic heart disease and systolic left ventricular dysfunction. (2011) (27)
High hematocrit as a risk factor for venous thrombosis. Cause or innocent bystander? (2010) (27)
Body height, mobility, and risk of first and recurrent venous thrombosis (2015) (26)
Impact of chronic kidney disease on the risk of clinical outcomes in patients with cancer‐associated venous thromboembolism during anticoagulant treatment (2013) (26)
Warfarin and aspirin after heart-valve replacement. (1994) (26)
Relationship between neighborhood socioeconomic status and venous thromboembolism: results from a population‐based study (2017) (26)
Hyperhomocysteinemia and Risk of First Venous Thrombosis: The Influence of (Unmeasured) Confounding Factors (2018) (25)
Statins and Risk of Bleeding: An Analysis to Evaluate Possible Bias Due to Prevalent Users and Healthy User Aspects. (2016) (24)
Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study (2019) (24)
Venous thrombosis following lower-leg cast immobilization and knee arthroscopy: From a population-based approach to individualized therapy. (2019) (24)
Existing data sources in clinical epidemiology: the Scandinavian Thrombosis and Cancer Cohort (2015) (24)
Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP) (2019) (23)
Disease prevalence dependent failure rate in diagnostic management studies on suspected deep vein thrombosis: communication from the SSC of the ISTH (2017) (23)
Genes associated with venous thromboembolism in colorectal cancer patients (2018) (23)
Major bleeding risks of different low‐molecular‐weight heparin agents: a cohort study in 12 934 patients treated for acute venous thrombosis (2017) (23)
Travel-related thrombosis. (2012) (22)
Mild antithrombin deficiency and risk of recurrent venous thromboembolism: results from the MEGA follow‐up study (2018) (21)
Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial (2019) (21)
Nationwide claims data validated for quality assessments in acute myocardial infarction in the Netherlands (2017) (21)
Vitamin supplementation on the risk of venous thrombosis: results from the MEGA case-control study. (2015) (21)
Pre-infarction angina predicts thrombus burden in patients admitted for ST-segment elevation myocardial infarction. (2012) (21)
Self‐reported therapy adherence and predictors for nonadherence in patients who switched from vitamin K antagonists to direct oral anticoagulants (2020) (20)
Prolactin and Venous Thrombosis: Indications for a Novel Risk Factor? (2011) (20)
Hypertensive Complications of Pregnancy and Risk of Venous Thromboembolism (2020) (19)
Pregnancy and travel-related thromboembolism. (2013) (19)
Levels of prolactin in relation to coagulation factors and risk of venous thrombosis (2012) (19)
Predictors, time course, and outcomes of persistence patterns in oral anticoagulation for non-valvular atrial fibrillation: a Dutch Nationwide Cohort Study (2021) (19)
Suspected survivor bias in case-control studies: stratify on survival time and use a negative control. (2014) (18)
Elevated levels of factor VIII and subsequent risk of all‐cause mortality: results from the MEGA follow‐up study (2015) (18)
The risk of venous thrombosis after air travel: contribution of clinical risk factors (2014) (18)
Association of Traditional Cardiovascular Risk Factors With Venous ThromboembolismClinical Perspective (2017) (18)
Influence of World Thrombosis Day on digital information seeking on venous thrombosis: a Google Trends study (2016) (18)
Impact of time since diagnosis and mortality rate on cancer‐associated venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) cohort (2018) (17)
Epidemiology of venous thromboembolism in hematological cancers: The Scandinavian Thrombosis and Cancer (STAC) cohort. (2017) (17)
Importance of Reperfusion Status after Intra-Arterial Thrombectomy for Prediction of Outcome in Anterior Circulation Large Vessel Stroke (2018) (17)
ORAL ANTICOAGULANT DRUGS. AUTHOR'S REPLIES (1992) (17)
Can we prevent venous thrombosis with statins: an epidemiologic review into mechanism and clinical utility (2016) (17)
Effect of gender‐affirming hormone use on coagulation profiles in transmen and transwomen (2021) (16)
Recurrent venous thrombosis related to overweight and obesity: results from the MEGA follow‐up study (2017) (16)
In-hospital major bleeding and its clinical relevance in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention. (2013) (16)
Paroxysmal Finger Haematoma: A Neglected Syndrome (1991) (16)
Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review (2018) (16)
Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study (2020) (16)
was based been excluded from trials on which the indication for anticoagulation Bleeding in patients receiving vitamin K antagonists who would have (2013) (15)
Patients with early arthritis consume less alcohol than controls, regardless of the type of arthritis. (2013) (15)
An observational study on survival rates of patients with out-of-hospital cardiac arrest in the Netherlands after improving the ‘chain of survival’ (2019) (15)
Association of apolipoproteins C-I, C-II, C-III and E with coagulation markers and venous thromboembolism risk (2019) (15)
Venous thromboembolism risk stratification for patients with lower limb trauma and cast or brace immobilization (2019) (14)
Risk of venous thrombosis in persons with increased body mass index and interactions with other genetic and acquired risk factors (2016) (14)
Coagulopathy after hemorrhagic traumatic brain injury, an observational study of the incidence and prognosis (2019) (14)
CANCER-ASSOCIATED THROMBOTIC DISEASE Epidemiology of cancer-associated venous thrombosis (2013) (14)
Post-thrombotic syndrome: Short and long-term incidence and risk factors. (2019) (14)
The increased risk of venous thromboembolism by advancing age cannot be attributed to the higher incidence of cancer in the elderly: the Tromsø study (2014) (14)
Clinical risk assessment model to predict venous thromboembolism risk after immobilization for lower-limb trauma (2020) (14)
Patients who underwent total hip or knee arthroplasty are more physically active than the general Dutch population (2016) (14)
Predictors of response to intramyocardial bone marrow cell treatment in patients with refractory angina and chronic myocardial ischemia. (2014) (13)
Mortality differences in acute myocardial infarction patients in the Netherlands: The weekend‐effect (2018) (13)
Antibiotic use as a marker of acute infection and risk of first and recurrent venous thrombosis (2017) (13)
Randomized trial of one-hour sodium bicarbonate vs standard periprocedural saline hydration in chronic kidney disease patients undergoing cardiovascular contrast procedures (2018) (13)
Caging the dragon: Research approach to COVID‐19–related thrombosis (2021) (12)
Increased risk of major bleeding after a minor bleed during treatment with vitamin K antagonists is determined by fixed common risk factors (2016) (12)
Statin Therapy to Revert Hypercoagulability and Prevent Venous Thromboembolism: A Narrative Review (2019) (12)
Determinants of impaired renal and vascular function are associated with elevated levels of procoagulant factors in the general population (2018) (12)
Endogenous sex hormones and risk of venous thromboembolism in young women (2019) (11)
Hospital‐acquired anemia: the contribution of diagnostic blood loss (2015) (11)
Individualized Thromboprophylaxis in Patients with Lower-Leg Cast Immobilization—A Validation and Subgroup Analysis in the POT-CAST Trial (2019) (11)
A case of thrombosis at high altitude (2005) (11)
Rise of levels of von Willebrand factor and factor VIII with age: Role of genetic and acquired risk factors. (2020) (10)
Validation of risk assessment models for venous thrombosis in hospitalized medical patients (2019) (10)
Application and comparison of the FADES, MADIT, and SHFM-D risk models for risk stratification of prophylactic implantable cardioverter-defibrillator treatment (2017) (10)
Lipid levels and risk of recurrent venous thrombosis: results from the MEGA follow‐up study (2017) (10)
Major Haemorrhage during Vitamin K Antagonist Treatment: The Influence of Thyroid Hormone Levels (2014) (10)
Glucocorticoid use and risk of first and recurrent venous thromboembolism: self‐controlled case‐series and cohort study (2021) (9)
Multi‐dose drug dispensing as a tool to improve medication adherence: A study in patients using vitamin K antagonists (2018) (9)
The incidence of venous thromboembolism in commercial airline pilots: a cohort study of 2630 pilots (2014) (9)
Theme 2: Epidemiology, Biomarkers, and Imaging of Venous Thromboembolism (and postthrombotic syndrome). (2015) (9)
Statin use and risk of recurrent venous thrombosis: results from the MEGA follow‐up study (2017) (9)
The joint effect of genetic risk factors and different types of combined oral contraceptives on venous thrombosis risk (2020) (9)
Erythropoiesis-stimulating agents and cardiovascular events in patients with myelodysplastic syndrome and multiple myeloma (2018) (9)
High risk of recurrent venous thrombosis in patients with lower‐leg cast immobilization (2018) (9)
Incidence and determinants of thrombotic and bleeding complications in patients with glioblastoma (2022) (8)
Travel and Venous Thrombosis: An Exercise in Thinking About Bias (2009) (8)
Surveillance of Second-Degree Relatives from Melanoma Families with a CDKN2A Germline Mutation (2013) (8)
Coffee consumption is associated with a reduced risk of venous thrombosis that is mediated through hemostatic factor levels (2012) (8)
Measurement of coagulation factors during rivaroxaban and apixaban treatment: Results from two crossover trials (2018) (8)
Thromboprophylaxis for lower leg cast immobilisation and knee arthroscopy: a survey study. (2015) (8)
Glucose levels and diabetes are not associated with the risk of venous thrombosis: results from the MEGA case‐control study (2018) (8)
More on clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism (2020) (8)
Factor V levels and risk of venous thrombosis: The MEGA case‐control study (2018) (8)
Association between micro particle-tissue factor activity, factor VIII activity and recurrent VTE in patients with acute pulmonary embolism (2015) (8)
Preventing VTE following total hip and knee arthroplasty: Is prediction the future? (2020) (7)
Inter‐ and intra‐individual concentrations of direct oral anticoagulants: The KIDOAC study (2021) (7)
Population-based 10-year cumulative revision risks after hip and knee arthroplasty for osteoarthritis to inform patients in clinical practice: a competing risk analysis from the Dutch Arthroplasty Register (2021) (7)
Platelet reactivity in patients with venous thrombosis who use rosuvastatin: a randomized controlled clinical trial (2016) (7)
The ERIKA trial: still limited evidence on the efficacy of thromboprophylaxis after knee arthroscopy (2016) (7)
Mechanical prophylaxis for travellers’ thrombosis: a comparison of three interventions that promote venous outflow (2007) (7)
The Risk of Venous Thrombosis Related to Increase in Body Mass Index Is Mediated by Factor VIII Induced APC-Resistance. (2009) (7)
Higher Adherence to Treatment With Low-Molecular-Weight-Heparin Nadroparin Than Enoxaparin Because of Side Effects in Cancer-Associated Venous Thromboembolism (2018) (7)
Thyroid disease and haemostasis : a relationship with clinical implications ? (2010) (7)
The course of pain and function in osteoarthritis and timing of arthroplasty: the CHECK cohort (2018) (7)
Hematological variables and venous thrombosis : red cell distribution width and blood monocytes are associated with an increased risk Running title : RDW , monocytes and venous thrombosis (2013) (7)
Epidemiology of Venous Thrombosis (2015) (6)
The association between leptin concentration and blood coagulation: Results from the NEO study. (2020) (6)
Risk prediction of recurrent venous thrombosis; where are we now and what can we add? (2019) (6)
Differential risks in men and women for first and recurrent venous thrombosis: the role of genes and environment: reply (2015) (6)
Management of anticoagulant therapy: The dutch experience (1996) (6)
Association of smoking and cancer with the risk of venous thromboembolism: the Scandinavian Thrombosis and Cancer cohort (2021) (6)
Coagulation activation during air travel is not initiated via the extrinsic pathway (2015) (6)
Switching from vitamin K antagonists to direct oral anticoagulants: Treatment satisfaction and patient concerns (2020) (6)
Venous Thrombosis Risk after Arthroscopy of the Knee: Derivation and Validation of the L-TRiP(ascopy) Score (2018) (6)
Cancer-related venous thromboembolism in the general population: results from the Scandinavian Thrombosis and Cancer (STAC) study (2015) (5)
High risk of venous thromboembolism after orthopedic surgery in patients with thrombophilia (2020) (5)
Long-Term Incidence of Venous Thromboembolism in Cancer: The Scandinavian Thrombosis and Cancer Cohort (2018) (5)
Increased risk of venous thrombosis after arterial thrombosis (2013) (5)
Persistence to direct oral anticoagulants for acute venous thromboembolism. (2018) (4)
Immune Determinants of Viral Clearance in Hospitalised COVID-19 Patients: Reduced Circulating Naïve CD4+ T Cell Counts Correspond with Delayed Viral Clearance (2022) (4)
Trigger Factors for Spontaneous Intracerebral Hemorrhage: A Case-Crossover Study (2021) (4)
High intensity of oral anticoagulant therapy in patients with cerebral haemorrhage: cause or consequence of the bleeding? (1997) (4)
The optimal intensity of oral anticoagulation therapy in patients with prosthetic heart valves (1992) (4)
Stability of vitamin K antagonist anticoagulation after COVID‐19 diagnosis (2021) (4)
Nonsustained Ventricular Tachycardia Is Independently Associated With Sustained Ventricular Arrhythmias in Nonischemic Dilated Cardiomyopathy. (2022) (4)
Exposure Opportunity: The Advantages of Including Men in Analyses of Female-Related Risk Factors (2017) (4)
Exercise-resembling effects of periodic somatosensory stimulation in heart failure. (2013) (4)
Switching from vitamin K antagonists to direct oral anticoagulants in non‐valvular atrial fibrillation patients: Does low time in therapeutic range affect persistence? (2021) (4)
The Risk for Venous Thrombosis in Patients with Increased Body Mass Index and Interactions with Other Genetic and Acquired Risk Factors: The MEGA Study (2011) (3)
The Immediate Effect of COVID-19 Vaccination on Anticoagulation Control in Patients Using Vitamin K Antagonists (2021) (3)
Acute splanchnic venous thrombosis: surgical and medical treatment with special emphasis on new aspects of coagulation disorders. (1997) (3)
Statin Use and Risk Of Recurrent Venous Thrombosis: Results From The MEGA Follow-Up Study (2013) (3)
Design and rationale of DUTCH-AF: a prospective nationwide registry programme and observational study on long-term oral antithrombotic treatment in patients with atrial fibrillation (2020) (3)
Control of anticoagulation with VKAs: overestimation of median TTR when assessed by linear extrapolation: A comment (2017) (3)
Clinical Factors and Recurrent Venous Thrombotic Events—Reply (2005) (3)
[Prevention of contrast-induced nephropathy: time for nuance and a new guideline]. (2013) (3)
Abstract 17645: Randomized Trial of 1-hour Sodium Bicarbonate Vs. Standard Saline Hydration in Patients With Chronic Kidney Disease Undergoing Intra-arterial Contrast Administration (2014) (3)
Predicting the risk of recurrent venous thrombosis: What the future might bring (2019) (3)
Sex‐specific aspects of venous thromboembolism: What is new and what is next? (2022) (3)
Varying incidences of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: the final thread that links them all (2016) (2)
Association Between Hepatic Triglyceride Content and Coagulation Factors (2020) (2)
The Risk of Venous Thrombosis in Different Immigrant Groups in the Netherlands (2012) (2)
Plasma Levels of Free Thyroxine and Risk of Major Bleeding in Bariatric Surgery (2016) (2)
Risk of cancer in patients with thyroid disease and venous thromboembolism (2018) (2)
Recurrent venous thrombosis in premenopausal women : effect of hormonal contraceptive use (2013) (2)
Rosuvastatin treatment decreases plasma procoagulant phospholipid activity after a VTE: A randomized controlled trial (2021) (2)
With ST Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention (2013) (2)
Illustrated State‐of‐the‐Art Capsules of the ISTH 2020 Congress (2021) (2)
Hyperhomocysteinaemia and the risk of recurrent venous thrombosis: results from the MEGA follow‐up study (2019) (2)
Direct oral anticoagulant use and subsequent start of proton pump inhibitors as proxy for gastric complaints (2018) (2)
Prevalence, Treatment, and Prognosis of Tumor Thrombi in Renal Cell Carcinoma (2022) (2)
Sex Differences in Risk Factors, Clinical Presentation, Treatment and Outcomes of Patients Presenting with Acute Pulmonary Embolism (2019) (2)
Plasma levels of Midkine (neurite growth‐promoting factor 2) are not associated with plasma fibrinolytic potential or risk of venous thrombosis (2012) (2)
Prevalence, risk factors, and long-term outcomes of cerebral ischemia in hospitalized COVID-19 patients – study rationale and protocol of the CORONIS study: A multicentre prospective cohort study (2022) (1)
[Thromboprophylaxis in outpatients with cancer?]. (2014) (1)
Nadroparin Plus Compression Stockings versus Nadroparin Alone for Prevention of Venous Thromboembolism in Cerebellopontine Angle Tumour Excisions: A Cohort Study (2020) (1)
Recurrence after stopping anticoagulants in women with combined oral contraceptive‐associated venous thromboembolism: A systematic review and meta‐analysis (2022) (1)
High Soluble Thrombomodulin Is Associated with an Increased Risk of Major Bleeding during Treatment with Oral Anticoagulants: A Case–Cohort Study (2020) (1)
Effect of lower‐leg trauma and knee arthroscopy on procoagulant phospholipid‐dependent activity (2022) (1)
Correction: Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP) (2021) (1)
Risk of Recurrence after Stopping Anticoagulants in Women with Combined Oral Contraceptive-Associated Venous Thromboembolism: A Systematic Review and Meta-Analysis (2021) (1)
[Acetylsalicylic acid in patients with diabetes for the primary prevention of cardiovascular disease]. (2004) (1)
Tumor‐expressed microRNAs associated with venous thromboembolism in colorectal cancer (2022) (1)
Cast immobilization of the lower-leg: No indication for thromboprophylactic therapy. (2017) (1)
[Suspicion of pulmonary embolism: added value of CT depends on patient characteristics and referring individual]. (2012) (1)
The Immediate Effect of COVID-19 Vaccination on Anticoagulation Control in Patients Using Vitamin K Antagonists (2021) (1)
Thromboprophylaxis after hospital discharge in acutely ill medical patients: need for trials in patients who are at high risk of venous thrombosis. (2017) (1)
Is deep-vein thrombosis always the origin of pulmonary embolism? Imaging of veins with a total-body direct thrombus MRI technique (2011) (1)
Abstract 12835: Randomized Study of Short Prehydration with Sodium Bicarbonate versus Standard Pre- and Posthydration with Sodium Chloride to Prevent Contrast Induced Acute Kidney Injury: The Salina Trial (2012) (1)
Response to letter regarding article, "Impact of incident venous thromboembolism on risk of arterial thrombotic diseases". (2014) (1)
Lower-leg injury and knee arthroscopy have distinct effects on coagulation (2022) (1)
A Replication Study of Gene Variants Associated with Venous Thrombosis. Results From a Population-Based Nested Case-Cohort Study. (2009) (1)
Adherence to direct oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study (2021) (1)
Confounding by Indication: Letter to the Editor (2016) (1)
Thromboprophylaxis in temporary lower limb immobilization: Extrapolate with care (2020) (1)
The association of complement C 3 genotype with coronary artery disease , markers of the metabolic syndrome and C 3 plasma levels (2006) (1)
Effectiveness of endolymphatic duct blockage versus endolymphatic sac decompression in patients with intractable Ménière’s disease: study protocol for a double-blinded, randomised controlled trial (2021) (1)
A simple risk score list can be used to predict the occurrence of delirium in patients admitted to inpatient hospice care: A medical record study (2022) (1)
Impact of incident venous thromboembolism on future risk of arterial thrombotick disease (2013) (1)
Targeted proteomics for evaluating risk of venous thrombosis following traumatic lower‐leg injury or knee arthroscopy (2021) (1)
Letter to the editor: Does long-term use of analgesics increase the risk of radiographic progression of knee osteoarthritis and future total knee replacement? (2017) (0)
Abstract 12781: Statin Use and Venous Thromboembolism Recurrence: A Combined Nationwide Cohort and Nested Case-control Study (2013) (0)
Risk and prognosis of in-hospital major bleeding after primary percutaneous coronary intervention for ST-elevation myocardial infarction (2013) (0)
THE VALUE OF SERUM TROPONIN-T TO PREDICT INFARCT SIZE IN PATIENTS WITH FIRST ST ELEVATION MYOCARDIAL INFARCTION TREATED WITH PRIMARY PERCUTANEOUS CORONARY INTERVENTION IN THE ERA OF HIGH SENSITIVE TROPONIN ASSAYS (2012) (0)
P14.01 Incidence and impact of venous thromboembolism and major bleeding in patients with glioblastoma (2021) (0)
Estimating Venous Thromboembolism Risk in Foot and Ankle Surgical Patients: A Base-Population Case-Control Study (2019) (0)
Risk of Venous Thrombosis Associated with White Cell Count On Peripheral Blood and Its Interrelationship with Other Environmental Risk Factors (2012) (0)
The Association of Tumor-Expressed REG4, SPINK4 and Alpha-1 Antitrypsin with Cancer-Associated Thrombosis in Colorectal Cancer (2023) (0)
List of contributors (2021) (0)
The association of genetic variants in the cholesteryl ester transfer protein gene with hemostatic factors and a first venous thrombosis (2019) (0)
MicroRNAs as prognostic biomarkers for (cancer-associated) venous thromboembolism. (2023) (0)
The risk of venous thrombosis in patients with malignancy is largely mediated through levels of factor VIII and von Willebrand factor (2013) (0)
Time Trends in Patient Characteristics, Anticoagulation Treatment, and Prognosis of Incident Nonvalvular Atrial Fibrillation in the Netherlands (2023) (0)
List of Contributors (2019) (0)
Enhanced in vivo and ex vivo thrombin generation after lower-leg trauma, but not after knee arthroscopy (2023) (0)
A case of thrombosis: Not sickle cell (2006) (0)
The risk of venous thromboembolism after minor surgical procedures: A population-based case-control study. (2022) (0)
Predictive value of the HAS-BLED score in patients with atrial fibrillation and chronic kidney disease using vitamin K-antagonists (2013) (0)
Chronic thromboembolic pulmonary hypertension and clot resolution after COVID-19-associated pulmonary embolism (2023) (0)
Front & Back Matter (2012) (0)
Left-sided Predominance of Deep Venous Thrombosis in the Postpartum Period (2016) (0)
OP-EHEA210428_online 4126..4138 (2021) (0)
Recurrent Venous Thrombosis (2013) (0)
2 Stroke October 2015 the Dutch Multiple Environmental and Genetic Assessment of Risk Factors for Venous Thrombosis ( MEGA ) study (0)
Risk of Venous Thromboembolism in Hematological Malignancies: The Scandinavian Thrombosis and Cancer Cohort (2015) (0)
TEMPORARY REMOVAL: OC-05: Thromboembolism after incident colorectal cancer in the Netherlands: incidence, predictors, and prognosis. (2022) (0)
Homocysteine levels and risk of first venous thrombosis: the influence of (unmeasured) confounding factors (2016) (0)
Malignancies and risk of recurrent venous thrombosis (2011) (0)
deep-vein thrombosis as 2 sides of the spectrum Broadening the factor V Leiden paradox: pulmonary embolism and (2013) (0)
Atrial fibrillation in cancer: thromboembolism and bleeding in daily practice. (2023) (0)
Tumor-expressed Factor VII associates with survival and regulates tumor progression in breast cancer. (2023) (0)
Clinical Haemostasis and Thrombosis Body height , mobility , and risk of first and recurrent venous thrombosis Running head : Body height , mobility , and venous thrombosis (2015) (0)
Oral anticoagulant drugs. (1992) (0)
Nutrition and venous thrombosis: An exercise in thinking about survivor bias (2018) (0)
Coagulation factor levels in relation to venous thrombosis and cancer: Results from the MEGA study (2016) (0)
49 – Travelers' Thrombosis (2013) (0)
PO-80 Tissue factor and tissue factor in combination with alpha-1 antitrypsin or REG4 associate with venous thromboembolism in patients with colorectal cancer (2021) (0)
Impact of initial cancer stage on the risk of venous thromboembolism: The Scandinavian Thrombosis and Cancer (STAC) Study (2015) (0)
Medical compliance after acute myocardial infarction in STEMI and NSTEMI patients in the Netherlands (2016) (0)
PO-13 Survival after cancer-related venous thrombosis: the Scandinavian Thrombosis and Cancer Study (STAC) (2021) (0)
Supplementary Material for: Plasma Levels of Free Thyroxine and Risk of Major Bleeding in Bariatric Surgery (2016) (0)
Predisposing factors for first and recurrent venous thrombosis (2018) (0)
THA/TKA PATIENTS ARE MORE PHYSICALLY ACTIVE THAN THE GENERAL POPULATION (2017) (0)
Prevention of venous thrombosis after an anterior cruciate ligament reconstruction : compression stockings alone vs. its combination with low molecular weight heparin (2015) (0)
Procoagulant factors and future risk of arterial cardiovascular disease in patients with prior venous thrombosis: A cohort study (2023) (0)
Impact of Time Since Diagnosis and Mortality Rate on Cancer-associated Venous Thromboembolism in a General Population - The Scandinavian Thrombosis and Cancer (STAC) Cohort (2017) (0)
No Evidence for Effective Prevention of Venous Thromboembolism With Low-Molecular-Weight Heparin After Anterior Cruciate Ligament Reconstruction: Letter to the Editor (2020) (0)
Moderate cross-sex hormone-induced prothrombotic changes of hemostatic variables in transgender subjects (2016) (0)
TL 18040 - Venous thromboembolism risk in foot and ankle surgical patients (2019) (0)
A case of thrombosis at high altitude Case Report (2005) (0)
THE EFFECT OF ICD REPLACEMENT ON THE REQUIREMENT FOR SURGICAL RE-INTERVENTION DUE TO INFECTIOUS AND NON-INFECTIOUS CAUSES. (2010) (0)
The Association Between Atherosclerosis and Venous Thrombosis: Results From the Tromsø Study. (2012) (0)
The influence of lower-leg injury and knee arthroscopy on natural anticoagulants and fibrinolysis. (2022) (0)
Risk of venous thrombo-embolism in female malignancies: the Scandinavian Thrombosis and Cancer Cohort (2016) (0)
The risk of venous thrombosis after a symptomatic arterial event in an older population (2013) (0)
Ch apter 3 Pre-infarction angina predicts thrombus burden in patients admitted for ST-segment elevation myocardial infarction (2011) (0)
The risk of venous thrombosis in oral contraception users with a history of superficial thrombophlebitis (2013) (0)
Targeted DNA sequencing to identify genetic aberrations in glioblastoma that underlie venous thromboembolism; a cohort study. (2022) (0)
Abstract 14585: Contrast Induced Acute Kidney Injury and Clinical Outcome after Intra-Arterial and Intravenous Contrast Administration: Risk Assessment Adjusted for Patient Characteristics by Design (2012) (0)
Association of Risk of Incident and Recurrent Venous Thromboembolism with Oral Glucocorticoid Treatment (2018) (0)
Cohort profile: The Scandinavian Thrombosis and Cancer (STAC) Study (2015) (0)
2016 Reviewer Acknowledgment (2017) (0)
Admission prothrombin fragment F1 + 2 levels and mortality in acute coronary syndromes (1997) (0)
Practice of Epidemiology Exposure Opportunity: The Advantages of Including Men in Analyses of Female-Related Risk Factors (2017) (0)
Abstract 13093: Increased Arterial Thrombo-Embolic Events and Major Bleeding in Patients with Atrial Fibrillation and Chronic Kidney Disease on Vitamin K-Antagonist Treatment (2012) (0)
Age should not be considered a risk factor for cancer-related venous thromboembolism: Results from the Scandinavian thrombosis and cancer study (2015) (0)
Survival after Cancer-related Venous Thrombosis: the Scandinavian Thrombosis and Cancer Study. (2023) (0)
Abstract 13114: Predictive Value of the Has-Bled Score in Patients with Atrial Fibrillation and Chronic Kidney Disease Using Vitamin K-Antagonists (2012) (0)
Abstract 15795: Hydration Prior to CT-Pulmonary Angiography is Not Required for Prevention of Contrast Induced-Acute Kidney Injury: The Randomized Nefros Trial (2013) (0)
Atrial fibrillation in patients with a history of cancer and risk of bleeding complications associated with antithrombotic therapy (2021) (0)
259Mortality differences in acute myocardial infarction in the Netherlands: “The Weekend-effect” (2017) (0)
Red cell distribution width and blood monocytes are associated with an increased risk of venous thrombosis (2013) (0)
Reply to letter to the editor by Koza et al. (2013) (0)
Statins in venous thrombosis: biochemical approaches to limiting vascular disease (2021) (0)
Infection at a Military Medical Center Colonization and Acinetobacter baumannii Diversity and Clinical Impact of (2012) (0)
The risk of venous thrombosis varies in different ethnic groups (2013) (0)
Survival after cancer-associated venous thrombosis: Results from the Scandinavian Thrombosis and Cancer (STAC) study (2015) (0)
Travelers' Thrombosis (2019) (0)
PROLONGATION OF LIFE WITH IMPLANTABLE CARDIOVERTER DEFIBRILLATOR TREATMENT IN THE ELDERLY (2011) (0)
Role of Routine Laboratory Tests in Assessing Risk of Recurrent Venous Thrombosis: Results from the MEGA Follow-Up Study (2018) (0)
2017 Reviewer Acknowledgment (2018) (0)
Pot-(K)Cast: Thrombosis prophylaxis after knee arthroscopy or during plaster cast lower leg immobilisation: determining the balance between benefits and risks (2011) (0)
Toward a tailored diagnostic standard for future diagnostic studies in pulmonary embolism: Communication from the SSC of the ISTH (2021) (0)
Influence of rosuvastatin on apolipoproteins and coagulation factor levels: Results from the STAtin Reduce Thrombophilia trial (2023) (0)
Estimating incidence of venous thromboembolism in COVID‐19: Methodological considerations (2022) (0)
Absence of rapid T cell control corresponds with delayed viral clearance in hospitalised COVID-19 patients (2021) (0)
Long-term follow-up of primary and secondary prevention implantable cardioverter deﬁbrillator patients (2011) (0)
The (T) thrombosis (I) in patients with (L) lower (L) limb (I) injuries (R)requiring (I) immobilisation (TILLIRI) study: A prospective observational multicentre study (2020) (0)
Venous and Arterial Thromboembolism in the Aging Population (2019) (0)
excluded from trials on which the indication for anticoagulation was based Bleeding in patients receiving vitamin K-antagonists that would have been (2013) (0)
No time to waste; the impact of the COVID-19 pandemic on hip, knee, and shoulder arthroplasty surgeries in the Netherlands and Denmark (2022) (0)
Risk of venous thromboembolism and major bleeding in the clinical course of osteosarcoma and Ewing sarcoma. (2022) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Suzanne C. Cannegieter?

Suzanne C. Cannegieter is affiliated with the following schools: